Clinical Trial

Efficacy and Safety of SurgiFill™in Patients With Femur or Tibia Fracture

Terminated
View on ClinicalTrials.gov →
Why the trial stopped
The study was terminated early due to company reasons.
Summary
This study is designed to investigate the safety and efficacy of SurgiFill™, a bone grafting material, in patients with femur or tibia fracture.
Trial Details
NCT Number NCT07518836
Lead Sponsor Cellontech Co., Ltd.
Conditions Bone Fracture, Tibia Fracture, Femur Fracture
Enrollment 60 participants
Start Date 2013-02
Primary Completion 2016-08 (estimated)
Study Completion 2016-12 (estimated)
Updated on ClinicalTrials.gov 2026-04-09